238 related articles for article (PubMed ID: 30031098)
21. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
[TBL] [Abstract][Full Text] [Related]
22. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases.
Cimino A; Halushka M; Illei P; Wu X; Sukumar S; Argani P
Breast Cancer Res Treat; 2010 Oct; 123(3):701-8. PubMed ID: 20012351
[TBL] [Abstract][Full Text] [Related]
23. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
24. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients.
Shin SJ; DeLellis RA; Ying L; Rosen PP
Am J Surg Pathol; 2000 Sep; 24(9):1231-8. PubMed ID: 10976697
[TBL] [Abstract][Full Text] [Related]
25. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
[TBL] [Abstract][Full Text] [Related]
26. Strong androgen receptor expression can aid in distinguishing GATA3+ metastases.
Boto A; Harigopal M
Hum Pathol; 2018 May; 75():63-70. PubMed ID: 29408697
[TBL] [Abstract][Full Text] [Related]
27. A case of synchronous double primary lung cancer with neuroendocrine features.
Niho S; Yokose T; Nagai K; Nishiwaki Y; Kodama T; Mukai K
Jpn J Clin Oncol; 1999 Apr; 29(4):219-25. PubMed ID: 10340047
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine Tumors of the Breast.
Rosen LE; Gattuso P
Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
Wu JM; Fackler MJ; Halushka MK; Molavi DW; Taylor ME; Teo WW; Griffin C; Fetting J; Davidson NE; De Marzo AM; Hicks JL; Chitale D; Ladanyi M; Sukumar S; Argani P
Clin Cancer Res; 2008 Apr; 14(7):1938-46. PubMed ID: 18381931
[TBL] [Abstract][Full Text] [Related]
30. Metastatic mammary carcinomas with endocrine features: potential diagnostic pitfalls.
Saqi A; Oster MW; Vazquez MF
Diagn Cytopathol; 2005 Jul; 33(1):49-53. PubMed ID: 15945084
[TBL] [Abstract][Full Text] [Related]
31. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
32. [Neuroendocrine differentiation in breast cancer].
Kreipe HH
Pathologe; 2019 Dec; 40(Suppl 3):325-330. PubMed ID: 31781853
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
34. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
36. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.
Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
World J Gastroenterol; 2015 Mar; 21(10):3132-8. PubMed ID: 25780316
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine breast cancer.
Graça S; Esteves J; Costa S; Vale S; Maciel J
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22891013
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
39. Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases.
Venable ER; Kerr SE; Lopes MBS; Jones KA; Bellizzi AM; Mounajjed T; Raghunathan A; Hamidi O; Halfdanarson TR; Ryder M; Graham RP
Diagn Pathol; 2020 Jul; 15(1):81. PubMed ID: 32622369
[TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
